Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
2019 · Science · 1,094 citations
https://doi.org/10.1126/science.aav2588
A
Ada Tam
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
274
Papers
10.2K
Citations
40
h-index
52
i10-index
Ada Tam is an academic researcher from Bloomberg (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immune cells in cancer & Cancer Research and Treatments. The author has an h-index of 40, co-authored 233 publications.
ORCID: 0000-0001-6828-5290Papers by this author
worksTranscriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
2021 · Nature · 519 citations
https://doi.org/10.1038/s41586-021-03752-4
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2016 · Clinical Cancer Research · 454 citations
https://doi.org/10.1158/1078-0432.ccr-15-1535
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
2020 · Journal of Clinical Investigation · 404 citations
https://doi.org/10.1172/jci131859
The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis
2016 · Mucosal Immunology · 206 citations
https://doi.org/10.1038/mi.2016.53
Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities
2021 · Journal for ImmunoTherapy of Cancer · 147 citations
https://doi.org/10.1136/jitc-2021-003894
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat